Closing Bell: Medexus Pharmaceuticals Inc down on Thursday (MDP)

Medexus Pharmaceuticals Inc opened trading today at $2.41 and closed at $2.35. Intraday prices ranged from $2.35 to $2.45.

The price eased -2.49% from the previous day's close of $2.41.

Today across North America, the TSX Composite closed -1.68% at 22723.21, the S&P 500 closed 1.58% at 5522.30, the Dow Jones Industrial Average closed 0.24% at 40842.79 and the Nasdaq Composite closed 2.64% at 17599.40.

Medexus Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker MDP.

A total of 15,400 shares was traded during the session, with total trades of 35. On average, Medexus Pharmaceuticals Inc has traded 19,938 shares in the last five days and 48,731 year-to-date.

The TSX market on the whole today saw 907 price advancers against 4,327 declines and 72 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, the shares have gained 8.29% in the last 12 months, while in 2024, they have decreased -4.86%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $58.95 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Currently, Medexus Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..